VOYA Investment Management
CRMD icon

VOYA Investment Management’s CorMedix CRMD Stock Holding History

VOYA Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
14,135
+1,788
+14% +$14.1K ﹤0.01% 2346
2026
Q1 		$83.8K Hold
12,347
– – ﹤0.01% 2219
2025
Q4 		$144K Hold
12,347
– – ﹤0.01% 2208
2025
Q3 		$144K Sell
12,347
-5,331
-30% -$64.5K ﹤0.01% 2247
2025
Q2 		$218K Buy
17,678
+889
+5% +$9.81K ﹤0.01% 2295
2025
Q1 		$103K Sell
16,789
-869
-5% -$8.99K ﹤0.01% 2429
2024
Q4 		$143K Sell
17,658
-721,401
-98% -$7.21M ﹤0.01% 2492
2024
Q3 		$5.97M Buy
739,059
+719,799
+3,737% +$3.9M 0.01% 938
2024
Q2 		$83.4K Sell
19,260
-70
-0.4% -$356 ﹤0.01% 2712
2024
Q1 		$82K Sell
19,330
-3,753
-16% -$13K ﹤0.01% 2654
2023
Q4 		$86.8K Buy
23,083
+1,059
+5% +$3.64K ﹤0.01% 2786
2023
Q3 		$81.5K Buy
22,024
+3,699
+20% +$14.7K ﹤0.01% 2778
2023
Q2 		$72.7K Buy
+18,325
New +$90.7K ﹤0.01% 2864
2022
Q2 		– Sell
-15,367
Closed -$84K – 2795
2022
Q1 		$84K Hold
15,367
– – ﹤0.01% 2536
2021
Q4 		$70K Sell
15,367
-312
-2% -$1.55K ﹤0.01% 2716
2021
Q3 		$73K Hold
15,679
– – ﹤0.01% 2787
2021
Q2 		$108K Buy
15,679
+1,508
+11% +$12K ﹤0.01% 2760
2021
Q1 		$142K Buy
14,171
+1,060
+8% +$11.2K ﹤0.01% 2609
2020
Q4 		$97K Buy
13,111
+3,078
+31% +$20.9K ﹤0.01% 2567
2020
Q3 		$60K Hold
10,033
– – ﹤0.01% 2412
2020
Q2 		$63K Sell
10,033
-2,943
-23% -$13.6K ﹤0.01% 2415
2020
Q1 		$47K Hold
12,976
– – ﹤0.01% 2499
2019
Q4 		$94K Buy
+12,976
New +$79.3K ﹤0.01% 2560
2016
Q2 		– Sell
-4,432
Closed -$59K – 2563
2016
Q1 		$59K Hold
4,432
– – ﹤0.01% 2465
2015
Q4 		$45K Hold
4,432
– – ﹤0.01% 2543
2015
Q3 		$44K Hold
4,432
– – ﹤0.01% 2550
2015
Q2 		$86K Buy
+4,432
New +$152K ﹤0.01% 2639

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

VOYA Investment Management's CRMD Position: Q2 2026 in Review

VOYA Investment Management increased its CorMedix (CRMD) stake by 14% in Q2 2026, buying an estimated $14.1K and bringing the position to 14,135 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

VOYA Investment Management first reported a position in CRMD in Q2 2015 and has held it in 27 quarters since. The position peaked at $5.97M in Q3 2024. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • VOYA Investment Management held 14,135 shares of CorMedix worth $111K as of Q2 2026.
  • VOYA Investment Management bought 1,788 CorMedix shares in Q2 2026, an estimated $14.1K.
  • CorMedix made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2346 holding.
  • VOYA Investment Management first reported a position in CorMedix in Q2 2015 and has held it in 27 quarters since.
  • VOYA Investment Management's CorMedix position peaked at $5.97M in Q3 2024.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.